A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial pathogens.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1PWdQPT
No comments:
Post a Comment